Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Inventiva S.A.

IVEVFPNK
Healthcare
Biotechnology
$4.44
$0.00(0.00%)
U.S. Market opens in 9h 43m

Inventiva S.A. Fundamental Analysis

Inventiva S.A. (IVEVF) shows weak financial fundamentals with a PE ratio of -1.32, profit margin of -17.67%, and ROE of 5.38%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position30.35%
PEG Ratio0.07
Current Ratio2.96

Areas of Concern

ROE5.38%
Operating Margin-6.15%
We analyze IVEVF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -1535.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-1535.0/100

We analyze IVEVF's fundamental strength across five key dimensions:

Efficiency Score

Weak

IVEVF struggles to generate sufficient returns from assets.

ROA > 10%
-1.74%

Valuation Score

Excellent

IVEVF trades at attractive valuation levels.

PE < 25
-1.32
PEG Ratio < 2
0.07

Growth Score

Weak

IVEVF faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

IVEVF maintains a strong and stable balance sheet.

Debt/Equity < 1
-6.41
Current Ratio > 1
2.96

Profitability Score

Weak

IVEVF struggles to sustain strong margins.

ROE > 15%
5.38%
Net Margin ≥ 15%
-17.67%
Positive Free Cash Flow
No

Key Financial Metrics

Is IVEVF Expensive or Cheap?

P/E Ratio

IVEVF trades at -1.32 times earnings. This suggests potential undervaluation.

-1.32

PEG Ratio

When adjusting for growth, IVEVF's PEG of 0.07 indicates potential undervaluation.

0.07

Price to Book

The market values Inventiva S.A. at -45.93 times its book value. This may indicate undervaluation.

-45.93

EV/EBITDA

Enterprise value stands at -5.95 times EBITDA. This is generally considered low.

-5.95

How Well Does IVEVF Make Money?

Net Profit Margin

For every $100 in sales, Inventiva S.A. keeps $-17.67 as profit after all expenses.

-17.67%

Operating Margin

Core operations generate -6.15 in profit for every $100 in revenue, before interest and taxes.

-6.15%

ROE

Management delivers $5.38 in profit for every $100 of shareholder equity.

5.38%

ROA

Inventiva S.A. generates $-1.74 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.74%

Following the Money - Real Cash Generation

Operating Cash Flow

Inventiva S.A. generates limited operating cash flow of $-178.43M, signaling weaker underlying cash strength.

$-178.43M

Free Cash Flow

Inventiva S.A. generates weak or negative free cash flow of $-178.93M, restricting financial flexibility.

$-178.93M

FCF Per Share

Each share generates $-1.29 in free cash annually.

$-1.29

FCF Yield

IVEVF converts -26.79% of its market value into free cash.

-26.79%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-1.32

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.07

vs 25 benchmark

P/B Ratio

Price to book value ratio

-45.93

vs 25 benchmark

P/S Ratio

Price to sales ratio

29.70

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-6.41

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.96

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

5.38

vs 25 benchmark

ROA

Return on assets percentage

-1.74

vs 25 benchmark

ROCE

Return on capital employed

-0.90

vs 25 benchmark

How IVEVF Stacks Against Its Sector Peers

MetricIVEVF ValueSector AveragePerformance
P/E Ratio-1.3229.45 Better (Cheaper)
ROE538.39%779.00% Weak
Net Margin-1767.41%-24936.00% (disorted) Weak
Debt/Equity-6.410.26 Strong (Low Leverage)
Current Ratio2.964.65 Strong Liquidity
ROA-173.82%-19344.00% (disorted) Weak

IVEVF outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Inventiva S.A.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ